Event
ACI Forum on Pharma & Biotech Patent Litigation USA
Fish & Richardson Principal Martina Hufnal will speak on the panel "Hatch-Waxman Lightning Round: Examining New Trends in Paragraph IV Litigation" at the American Conference Institute (ACI) Forum on Pharma & Biotech Patent Litigation USA. The forum will be held October 14-15 in New York City. Session details are below.
Hatch-Waxman Lightning Round: Examining New Trends in Paragraph IV Litigation
Over the last several years, we have seen a significant reduction in blockbuster drugs, necessitating a reexamination of strategies in Paragraph IV litigation. Many of these strategies are things we’ve seen before with a new twist. This session will provide an overview of key actions and considerations influencing Paragraph IV litigation under Hatch-Waxman.
- Examining Paragraph IV litigation trends around patent thickets
- Understanding how new interpretations of the safe harbor will impact your litigation strategies
- ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited et al.
- The significance of denial of certiorari in Edwards Life Sciences v. Merril
- Examining prior art exceptions to the on-sale bar
- Determining litigation venue
- Deconstructing inducement of infringement and skinny labeling as a strategy and a threat